BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12127564)

  • 1. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens.
    Matsuo Y; Drexler HG; Takeuchi M; Tanaka M; Orita K
    Leuk Res; 2002 Sep; 26(9):873-9. PubMed ID: 12127564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
    Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
    Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genes.
    Makishima H; Ishida F; Saito H; Ichikawa N; Ozaki Y; Ito S; Ota M; Katsuyama Y; Kiyosawa K
    Eur J Haematol; 2003 Apr; 70(4):212-8. PubMed ID: 12656743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
    Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
    Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of lymphocyte phenotype and T cell receptor genotype in Felty's syndrome.
    Meliconi R; Kingsley GH; Pitzalis C; Sakkas L; Panayi GS
    J Rheumatol; 1992 Jul; 19(7):1058-64. PubMed ID: 1380988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD3(-) large granular lymphocyte leukemia with clonal rearrangement of the gamma and beta genes of the T-cell receptor.
    Manteiga R; Florensa L; Solé F; Prat M; Besses C; Woessner S
    Haematologica; 2000 Aug; 85(8):879-80. PubMed ID: 10942944
    [No Abstract]   [Full Text] [Related]  

  • 7. Translocation (3;5)(p26;q13) in a patient with chronic T-cell lymphoproliferative disorder.
    Schmidt HH; Pirc-Danoewinata H; Panzer-Grümayer ER; Sill H; Sedlmayr P; Neumeister P; Linkesch W; Haas OA
    Cancer Genet Cytogenet; 1998 Jul; 104(2):82-5. PubMed ID: 9666798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
    Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
    Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel T-cell lymphoma cell line established from a patient with systemic lupus erythematosus-associated lymphoma.
    Miyanishi S; Ohno H
    Cancer Genet Cytogenet; 1992 Apr; 59(2):199-205. PubMed ID: 1316225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement.
    Aoyama Y; Yamane T; Hino M; Ohta K; Nakamae H; Yamamura R; Koh KR; Takubo T; Inoue T; Tatsumi Y; Tatsumi N
    Ann Hematol; 2001 Dec; 80(12):752-4. PubMed ID: 11797118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
    Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
    J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells bearing gamma/delta T cell receptor and their expression of activation antigen in peripheral blood from patients with Sjögren's syndrome.
    Ichikawa Y; Shimizu H; Yoshida M; Takaya M; Arimori S
    Clin Exp Rheumatol; 1991; 9(6):603-9. PubMed ID: 1722441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.
    Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K
    Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.
    Ortaldo JR; Winkler-Pickett RT; Yagita H; Young HA
    Cell Immunol; 1991 Sep; 136(2):486-95. PubMed ID: 1714795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
    Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
    Koyasu S
    J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A novel phenotype (CD 4+, Leu 7+) in large granular lymphocyte leukemia: a case report].
    Ohno T; Miwa H; Anazawa H; Ikeda T; Kawakami K; Katayama N; Shirakawa S
    Rinsho Ketsueki; 1989 Feb; 30(2):222-6. PubMed ID: 2787420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
    Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y
    Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia.
    Gentile TC; Uner AH; Hutchison RE; Wright J; Ben-Ezra J; Russell EC; Loughran TP
    Blood; 1994 Oct; 84(7):2315-21. PubMed ID: 7522625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.